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Abstract
Pseudoxanthoma elasticum (PXE, OMIM 264800) is a rare autosomal recessive disorder with ectopic mineralization and
fragmentation of elastin fibers. It is caused by mutations of the ABCC6 gene that leads to decreased serum levels of inorganic
pyrophosphate (PPi) anti-mineralization factor. The occurrence of severe complications among PXE patients highlights the
importance of early diagnosis so that prompt multidisciplinary care can be provided to patients. We aimed to examine dermal
connective tissue with nonlinear optical (NLO) techniques, as collagen emits second-harmonic generation (SHG) signal, while
elastin can be excited by two-photon excitation fluorescence (TPF). We performed molecular genetic analysis, ophthalmological
and cardiovascular assessment, plasma PPi measurement, conventional histopathological examination, and ex vivo SHG and
TPF imaging in five patients with PXE and five age- and gender-matched healthy controls. Pathological mutations including one
new variant were found in the ABCC6 gene in all PXE patients and their plasma PPi level was significantly lower compared with
controls. Degradation and mineralization of elastin fibers and extensive calcium deposition in the mid-dermis was visualized and
quantified together with the alterations of the collagen structure in PXE. Our data suggests that NLO provides high-resolution
imaging of the specific histopathological features of PXE-affected skin. In vivo NLO may be a promising tool in the assessment
of PXE, promoting early diagnosis and follow-up.
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Introduction
Pseudoxanthoma elasticum (PXE, OMIM#264800) is a rare au-
tosomal recessive connective tissue disorder characterized by
ectopic mineralization and fragmentation of elastin fibers. At
the genetic level, homozygous or compound heterozygous loss-
of-function mutations in the ABCC6 gene (OMIM#603234) are
the main cause of PXE [1]. ABCC6 encodes an ATP binding
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cassette protein which is crucial for connective tissue homeosta-
sis. Loss-of-function of the ABCC6 protein results in reduced
ATP release from hepatocytes. Since extracellular ATP is rapidly
cleaved by ENPP1 to AMP and inorganic pyrophosphate (PPi),
in the absence of ABCC6, PPi levels and pyrophosphate/
phosphate ratio are decreased [2]. PPi is an anti-mineralization
factor, thus low plasma levels of PPi likely contribute to aberrant
ectopicmineralization.While low PPi levels unquestionably play
a critical role in the pathogenesis of PXE, the underlying mech-
anism of the ABCC6-dependent ATP release has not yet been
elucidated [2, 3]. Recently, it has been shown that plasma PPi
levels are decreased in PXE and other patients with ectopic min-
eralization. This is a biochemical hallmark of the disease and it
has been proposed that increasing the PPi level could be of ther-
apeutic use [4].
Due to strong inter- and intrafamilial heterogeneity in phe-
notypic expression, the diagnosis of PXE may be challenging
and often delayed. The prevalence of PXE is estimated to be
between 1 in 25,000 and 100,000 [5], with women twice as
likely to be affected [6]. Carrier frequency is appraised to be
about 1 per 100 [7].
Typically, skin symptoms develop first during adolescence
as yellowish papules appearing first on the neck, and later in
flexural areas [6, 8]. Papules can coalesce into reticulated
plaques resembling a cobblestone pattern and the skin be-
comes progressively slack, redundant, and inelastic.
Sometimes, skin changes can be minimal or absent even in
the presence of significant ocular or vascular manifestations
[9]. However, more severe skin lesions tend to co-occur with
more severe ophthalmological symptoms [10].
Ophthalmological manifestations usually appear several
years after the onset of skin signs. The most common ocular
findings in PXE are angioid streaks, which are disruptions of
the choroidal Bruch’s membrane [11]. Drusen-like retinal pig-
ment irregularities in the temporal part of the posterior pole
called “peau d’orange” are often early findings [12].
Cardiovascular involvement is mainly characterized by arte-
riosclerosis through the calcification of the media that affect
vessels of the extremities, coronary arteries, and the cerebral
circulation [13].
Though PXE skin lesions can be identified clinically in
most cases, skin biopsy and/or genetic analysis are required
to confirm the diagnosis. Typical histologic features include
short, fragmented, clumped, and calcified elastic fibers in the
mid-dermis, but abnormalities of collagen fibers can also be
observed [8, 9, 14].
However, the dermatologic diagnosis of PXE can be chal-
lenging due to its rarity, the often relatively late disease onset,
and the phenotypic heterogeneity. Therefore, PXE is
underdiagnosed and even if the diagnosis is established, it
usually takes several years after the manifestation of the first
symptoms [9, 15, 16]. In addition, PXE-like conditions, show-
ing a broad clinical spectrum and genetic heterogeneity, have
also been described, which should be considered in the differ-
ential diagnosis of PXE [17]. These include generalized arte-
rial calcification of infancy-1 and infancy-2 (GACI1 and
GACI2), caused by bi-allelic mutations in ENPP1 or
ABCC6, respectively [9], or the PXE-like syndrome with mul-
tiple coagulation factor deficiency, caused by bi-allelicGGCX
mutations [18].
Nonlinear optical (NLO) microscopy is a novel non-
invasive imaging technique which has been used to assess
morphologic changes in a wide array of dermatological con-
ditions, including skin cancer, metabolic disorders, and vari-
ous genodermatoses [19–23]. NLO processes can be generat-
ed by ultrafast, picosecond or femtosecond, laser pulses pro-
viding stain-free, and submicron resolution imaging of the
skin with deeper tissue penetration than reflectance confocal
microscopy. Distinct components of the dermal connective
tissue can be differentiated with NLO techniques. Collagen
emits a strong second-harmonic generation (SHG) signal
due to its non-centrosymmetric structure with high second-
order nonlinear susceptibility, while elastin, among different
endogenous chromophores, such as keratin and melanin, can
be visualized by another NLO technique, two-photon excita-
tion fluorescence (TPF) [24]. In addition, TPF was found to be
suitable for the detection of calcium depositions in artery walls
and to track calcified nodule growth in aortic valves ex vivo
[25, 26]. In our present study, we visualized calcification and
demonstrated the fragmentation of elastic fibers in the skin of
PXE patients utilizing NLO microscopy imaging that allows
the histologic diagnosis of the disease.
Methods
Patient data
Three female and two male PXE patients with a mean age of
53.8 ± 13.1 years were included in this study. All patients were
diagnosed and managed at the Department of Dermatology,
Venereology and Dermatooncology, the Department of
Ophthalmology, and the Heart and Vascular Center of
Semmelweis University, Budapest, Hungary. Best-corrected
visual acuity measurement, near vision test, slit lamp exami-
nation, fundoscopy, and optical coherence tomography (OCT)
were performed in all patients. All patients underwent cardio-
vascular evaluation which involved detailed history taking,
physical examination, electrocardiography, a comprehensive
echocardiographic examination, and carotid Doppler ultra-
sound. Patients’ data are summarized according to the
Phenodex scoring proposed by Legrand et al. [27]. The study
was approved by the local Ethics Committee in Budapest,
Hungary (SE TUKEB no. 193/2017) with the requirement
of written consent from all the participants.
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Plasma PPi measurements
Blood samples were collected from each patient and five age-
and gender-matched healthy volunteers who served as con-
trols. Platelet-free plasma was prepared, and PPi content was
determined as described by Jansen et al. [2]. Briefly, the blood
was drawn using a 22-gauge needle into CTAD containing
BD Vacutainer® tubes (Ref: 367599, Becton, Dickinson and
Company, Franklin Lakes, NJ, USA), supplemented with
50 μl of 15% K3 EDTA prior to sampling. The plasma frac-
tion was separated by centrifugation at 1000g 4 °C for 10 min
and transferred to platelet separation tubes (Centrisart I®
300.000 MW, 13279E, Sartorius, Göttingen, Germany).
Platelet-free plasma was prepared at 2200 g for 30 min, 4 °C
and stored at − 80 °C. PPi content of the samples was deter-
mined in an enzymatic way. First, PPi was converted to ATP
in an assay containing 80 μMMgCl2, 50mMHEPES pH 7.4,
32 mU/ml ATP sulfurylase (MO394L, New England Biolabs,
Ipswich, MA, USA), and 16 μM adenosine 5′-phosphosulfate
(A5508, Sigma-Aldrich, Saint Louis, MO, USA) by incubat-
ing samples/standards for 30 min at 37 °C followed by the
inactivation of the enzyme at 90 °C for 10 min. In a consec-
utive step, ATP content was determined in a bioluminescent
assay using 20 μl BacTiterGlo (G8230, Promega Madison,
WI, USA) for 20-μl sample/standard. PPi concentration of
plasma samples was calculated using calibration standards
and corrected for initial plasma ATP concentrations.
Molecular genetic testing
Molecular analysis of the ABCC6 gene
Genomic DNA was isolated from whole blood (QIAamp
blood kit, Qiagen®, Hilden, Germany) and the coding region
of the ABCC6 gene was amplified using an established proto-
col. Primer sequences are available upon request. Direct se-
quencing was performed using an Applied Biosystems 3730xl
Sequencer®, with ABI PRISM BigDye Terminator Cycle
Sequencing Kit (Applied Biosystems®, Foster City, CA,
USA). Nucleotide numbers are derived from gDNA ABCC6
sequences (GenBank accession no. NM_001171).
Multiplex ligation-dependent probe amplification
analysis
MLPA analysis of the ABCC6 gene was performed using the
SALSA MLPA kit PO92-B3 (MRC-Holland, Amsterdam,
The Netherlands) according to the manufacturer’s recommenda-
tions. MLPA fragments were detected using an ABI3130XL or
ABI3730XL capillary electrophoresis system (Applied
Biosystems, Foster City, CA, USA) and analyzed using
Coffalyser (MRC Holland, Amsterdam, The Netherlands).
Skin sample preparation and histopathology
Skin biopsies from PXE-affected not photoexposed areas of
all patients and five age-matched healthy controls were col-
lected, formalin-fixed, and paraffin-embedded. Skin sections
were stained with hematoxylin and eosin (H&E), Weigert’s
elastic (WE), von Kossa (VK), and Van Gieson (VG) stains.
WE was used to stain elastic fibers, VK to reveal CaP min-
erals, while collagen was stained by VG. Histopathologic
evaluation was performed by an expert dermatopathologist.
NLO microscopy imaging and image processing
Separate deparaffinized, unstained sections from the same
skin biopsies were prepared for NLO investigations. The uti-
lized NLO imaging setup has been previously described [22,
23]. In brief, a FemtoRose 100TUN NoTouch tunable, femto-
second pulse Ti-sapphire laser (R&D Ultrafast Lasers Ltd.,
Budapest, Hungary) was operated at 800-nm wavelength, de-
livering ~ 190 fs pulses at a ~ 76-MHz repetition rate. To focus
the laser beam, a 20× water immersion objective (W-Plan –
APOCHROMAT 20×/1.0 DIC (UV)VIS-IR, Carl Zeiss, Jena,
Germany) was employed. A commercial Axio Examiner LSM
7 MP laser scanning two-photon microscope system (Carl
Zeiss, Jena, Germany) with custom-modified detection optics
was used to capture images. TPF signal was separated with a
525/50-nm bandpass emission filter, while SHGwas collected
using a 405/20-nm filter. Mosaic images were captured from
multiple field of views (FOV) with an individual imaging area
of 420 × 420 μm2.
The acquired TPF and SHG images were merged and com-
posed into two-channel mosaic images with ImageJ v1.46
software (NIH, Bethesda, MD, USA). In each sample, ten
representative FOV were selected for further analyses. To de-
termine the ratio of calcification, calcium deposits were
outlined, their relative surface area was measured, and the
number and length of elastin fibers were counted manually
using ImageJ. CT-FIRE v.13 (LOCI, University of
Wisconsin –Madison,WI, USA), a curvelet-based framework
designed to analyze properties of collagen fibers was custom-
ized and run on the raw SHG images to calculate length and
width for single collagen fibers [28].
Statistical analysis
Unpaired, two-tailed Student’s t test, Mann-Whitney’s U test,
and linear regression were used for statistical analysis using
GraphPad Prism v6.0 software (GraphPad Software Inc., La
Jolla, CA USA). P values less than 0.05 were considered




Phenodex scores can be found in Table 1. Plasma PPi levels
for PXE patients were significantly lower than for healthy
controls (mean ± SD 0.232 ± 0.063 μM vs 0.947 ±
0.108 μM, respectively) (Fig. 1).
Molecular genetic testing
Bidirectional Sanger sequencing and MLPA analysis of
ABCC6 confirmed the diagnosis of PXE in all patients
(Table 1). In patients 1, 2, 3, and 5, compound heterozygous
bi-allelic pathogenic variants were identified. Moreover, in
patient 4, an exon deletion and a novel splice-site mutation,
c.1944-1G>C, have been detected. In silico mutational analy-
sis was carried out using Human Splicing Finder v3.1 soft-
ware (Aix Marseille Université, Marseille, France) in order to
estimate the impact of the novel variant. The c.1944-1G>C
change was predicted to fully disrupt the wild-type acceptor
site, underscoring the pathogenicity of this mutation [29].
Histopathology
The papillary dermis and the deep layers of the dermis appeared
to be unaffected in all patients. However, the mid-dermis of PXE
patients exhibited prominent changes. H&E staining showed ir-
regularly shaped, clumped, and faintly basophilic elastic fibers as
well as numerous fibroblasts (Fig. 2).WE staining revealed poly-
morphic, fragmented, and mineralized elastic fibers. VK staining
displayed mid-dermal salt deposits and clumps of calcified elas-
tin fibers, which were absent in the healthy samples. Finally, VG
staining revealed disrupted, abnormal collagen fibers surround-
ing abundant mineral deposits, comparedwith dense, interwoven
collagen structure in controls.
Table 1 Demographic data, Phenodex scores according to Legrand
et al. [27], and molecular genetic data of the ABCC6 gene in our PXE
patients. Updated Phenodex score assesses six organ systems—skin (S),
eye (E), gastrointestinal (G), vascular (V), cardiac (C), and renal (R)—to
create phenotypic categories based on clinical findings
Pt. no. Sex Age (y) Phenodex score Allele 1 Allele 2
Gene Protein Gene Protein
1 F 52 S2 E3 G0 V1 C0 R0 c.3421C>Ta p. R1141Xa c.1132C>Ta p.Q378Xa
2 F 52 S2 E3 G0 V1 C1 R0 c.1552C>Ta p.R518Xa c.3662G>Ab p.R1221Hb
3 M 34 S2 E2 G0 V0 C0 R0 c.105delAc p.Val37Serfs*44c c.3421C>Ta p.R1141Xa
4 M 68 S3 E2 G0 V0 C0 R0 c.1944-1G>Cd - exon 24-27delc -
5 F 63 S3 E3 G0 V1 C0 R0 c.3421C>Ta p. R1141Xa c.1484T>Ab p.L495Hb





Fig. 1 Plasma inorganic pyrophosphate (PPi) levels of our PXE patients
compared with age- and gender-matched healthy controls. Blood samples
were collected and platelet-free plasma was prepared. a Plasma PPi levels
of all included patients were determined by first converting PPi to ATP,
then measuring ATP content in a bioluminescent assay. PPi concentration
of plasma was calculated based on calibration standards and corrected for
initial plasma ATP concentration. b Plasma PPi levels in PXE vs control
patients (mean ± SD 0.232 ± 0.063 μM vs 0.947 ± 0.108 μM) were com-
pared using unpaired Student’s t test. *p < 0.05. Pt, patient; Co, control
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NLO microscopy imaging
NLO microscopic images of healthy and PXE-affected skin
samples are displayed in Fig. 3. In the mid-dermis of the
control samples, the TPF channels showed a network of wavy,
branching elastic fibers, while in the SHG channel, randomly
organized collagen bundles in a basket weave-like pattern
were observed. Conversely, the mid-dermis of PXE patients
comprised of spacious calcified areas and fragmented,
clumped elastin fibers as revealed by the TPF channel.
When we counted the number of elastin fibers (indicated with
numbering in the right-side panel of Fig. 4a) in PXE patients, a
significant increase has been found compared with healthy
controls (175.7 ± 79.49 vs 97.56 ± 29.30). Elastin fiber length
(outlined in blue in Fig. 4b) was significantly lower in PXE
(59.49 ± 0.66 μm vs 91.64 ± 5.6 μm). Measuring the calcium
deposit relative surface area (marked in yellow in Fig. 4c), we
found significant calcification to be present in each patient but
also that the general extent of calcification varied considerably
among patients. No calcification was found in the controls.
We also assessed if the extent of calcification correlated with
plasma PPi levels and found no association (data not shown).
SHG images from PXE patients showed sparsely distributed,
irregular, and sometimes coiled collagen fibers (Fig. 3). With
Fig. 2 Representative histology images of the mid-dermis of healthy and PXE-affected skin, stained with hematoxylin and eosin (H&E), Weigert’s
elastic (WE), von Kossa (VK), and Van Gieson’s (VG) staining. Red arrows, fibroblasts; black arrows, elastic fibers. Scale bars display 200 μm
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the use of CT-FIRE algorithm, we found significantly shorter
collagen fibers (67.99 ± 0.79 μm vs 73.53 ± 1.04 μm) and
decreased fiber width (6.8 ± 0.06 μm vs 7.33 ± 0.07 μm) in
the PXE samples compared with controls (Fig. 4d–e). Similar
to the histopathological analysis, the papillary dermis and
deep dermis were morphologically normal for all samples.
Discussion
The occurrence of severe complications among PXE patients
highlights the importance of early diagnosis so that prompt
multidisciplinary care can be provided to patients. Our results
confirm previous data that suggested that PXE patients have
PPi levels lower than 50% of the average healthy individual
[2, 30]. However, the range of PPi levels is wide, both in
patients and healthy individuals that complicate the interpre-
tation of PPi levels. Furthermore, variability between mea-
surements from different research laboratories suggests a need
for better standardization of the technique before assessing the
applicability PPi test in PXE.
In our cohort of 5 patients, we found the most frequent
mutation p.R1141X with an allele frequency of 0.3, which is
similar to what has been reported previously for the European
population [9]. Most of the other mutations we identified are
also frequent in this population, such as the large deletion of
ex 24-27 or the Q378X, which was reported to be a result of
gene conversion with ABCC6 pseudogene 1 [31, 32]. We
report here a novel splice-site mutation as well. In addition,
we described here a detailed protocol for the ABCC6 genetic
analysis in an attempt of standardization.
Generally, PXE is first suspected by a trained dermatologist
who notices the subtle clinical signs of the disease. Molecular
genetic testing for ABCC6 is a key step in the diagnosis of
PXE, but due to the low prevalence of PXE, its use is often
limited to the final confirmation of diagnosis [33]. While there
are various techniques for ophthalmologic and cardiovascular
assessment, currently, conventional histopathological exami-
nation is the sole widely applied objective method for the
diagnosis of skin lesions in PXE [8]. Unfortunately, the accu-
rate evaluation requires a skilled dermatopathologist [34, 35],
and the effectiveness and specificity of VK and elastic fiber
staining for the detection of calcification are often disputed.
Therefore, alternative approaches to the histopathological di-
agnosis are highly needed.
Here, we used NLO to determine whether this technique is
able to detect characteristic changes seen in PXE. We sought to
visualize calcification and to perform a novel numeric analysis
of the changes of connective tissue fibers in the skin of the
investigated patients utilizing NLO microscopy imaging. We
were able to show the degradation of elastin fibers in the sam-
ples of our PXE patients that confirm findings in previous his-
topathologic reports. In addition, we were able to visualize the
mineralization of elastin fibers as also a hallmark feature of the
disease.We showed here that the extensivemid-dermal calcium
deposition harbors endogenous fluorescent properties. In addi-
tion, we introduced a numeric method to quantify changes in
number and length of elastin fibers and the extent of calcifica-
tion, as the two could be clearly distinguished based on their
morphology in the captured submicronic resolution TPF im-
ages. The increase of number of elastin fiber count in PXE
patients is the result of fiber fragmentation that is a consequence
of aberrant mineralization [14]. The lack of correlation between
plasma PPi levels and the extent of calcification may be due to
the small cohort size.We also detected significant abnormalities
in the SHG images of collagen fibers. Impaired collagen
fibrillogenesis is a previously described feature of PXE, al-
though it was considered highly aspecific [14]. Given that pre-
vious findings of the collagen morphology in PXE were based
on conventional histopathology staining and SHG shows nota-
bly higher specificity to collagen, previous findings may need
to be revisited using SHG [36].
The unique previous report that used NLO imaging in PXE
analyzed a skin sample from a single PXE patient [37]. They
found the alteration of elastin fibers; however, the NLO setup
used in their study was not capable of visualizing calcium de-
posits, an important feature of PXE-affected skin. Based on our
findings, NLO seems to enable high-detail visualization of cal-
cium deposits and—more importantly—the alterations of elas-
tin fibers, the specific features of PXE-affected skin at early
stages. Thus, our setup provides a great improvement of the
technique and emphasizes the potential of NLO in the diagnos-
tics of PXE. NLO analysis revealed a complex pattern of mid-
dermal alterations in PXE patients. This opens new clinical
perspectives in the diagnosis and follow-up of PXE patients.
Although in the present study we applied label-free NLO mi-
croscopy imaging on ex vivo skin samples, handheld devices
capable of NLO microscopy imaging could be used for in vivo
diagnostics [38]. Further studies are needed to establish the
sensitivity and specificity of NLO approaches and their place
in the diagnostic workup of PXE. Indeed, NLO techniques are
promising tools to provide non-invasive “optical biopsies” of
the skin in various disorders and could replace conventional
histopathology which would decrease the disease burden for
patients. We propose this method to be used as an important
Fig. 3 Two-photon excitation fluorescence (TPF) and second-harmonic
generation (SHG) images of PXE-affected and healthy skin. TPF signal
(shown in green color) is mainly emitted by elastin in the dermis, while
SHG (magenta) displays the collagen structure, both generated at 800-nm
excitation wavelength. 420 × 420 μm2 frames were captured and assem-
bled into (a, b) mosaic images of skin samples with 300 × 300 μm2 high
zoom images of the dermis (α,β, γ, δ). aControl skin, b skin of patient 3.
High zoom inserts were marked with (c–j). Representative high zoom
images of the mid-dermis, c, d patient 1, e, f patient 2, g, h patient 4, i,
j patient 5. White arrows, elastin fibers; blue arrows, collagen fibers;
yellow arrows, calcium deposits. Scale bars display 500 μm for mosaic




tool for early and non-invasive diagnosis of PXE, prior to con-
firmation by genetic tests. Also, to date, non-invasive bio-
markers for the monitoring of treatment response in PXE are
not available, and serial skin biopsies would not be feasible as
scarring induces calcification. As various therapeutic options
have been proposed recently for PXE [3], non-invasive moni-
toring of efficacy could be an important application of NLO in
the future. Finally, one should note that in vivo NLO could also
be applicable for the detection, characterization, or monitoring
of other skin conditions with cutaneous calcinosis.
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